Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Cochlear implant with combined electrical stimulation and acoustic amplification

Número de PMA: P130016 · 2026-04-30

SolicitanteCochlear Americas
Fecha de decisión2026-04-30
Número PMAP130016
Código de productoPGQ
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorEN

Resumen del dispositivo

Cochlear implant with combined electrical stimulation and acoustic amplification is the device name listed in this FDA 510(k) record. The listed applicant is Cochlear Americas. It received FDA 510(k) clearance on 2026-04-30. The device is classified under product code PGQ. It was reviewed by the EN advisory panel.

Preguntas frecuentes

What is the Cochlear implant with combined electrical stimulation and acoustic amplification?

Cochlear implant with combined electrical stimulation and acoustic amplification is a medical device that received FDA 510(k) clearance on 2026-04-30. The listed applicant is Cochlear Americas.

When did Cochlear implant with combined electrical stimulation and acoustic amplification receive FDA 510(k) clearance?

The clearance date for Cochlear implant with combined electrical stimulation and acoustic amplification can be found in the official FDA records.

Who is the listed applicant for Cochlear implant with combined electrical stimulation and acoustic amplification?

The FDA 510(k) record lists Cochlear Americas as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Cochlear implant with combined electrical stimulation and acoustic amplification?

The FDA product code for Cochlear implant with combined electrical stimulation and acoustic amplification is PGQ.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑